Diagnostics for the RealWorld

DRW Focuses on Breakthrough Point-of-Care Diagnostics for Some of the World’s Most Devastating Infectious Diseases, Developed by the Diagnostic Development Unit at the University of Cambridge for Wide Availability. Its signal amplification technology enables rapid and reliable testing in resource-limited settings. DRW is currently focused on providing rapid Early Infant Diagnosis (EID) and Viral Load (VL) measurement for HIV-infected individuals, enabling testing and treatment facilities even in the most challenging and remote environments.